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ORIGINAL ARTICLE
LUNG IMAGING
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ABSTRACT
Objective: Improved pneumonia diagnostics are needed, particularly in resource-constrained settings.
Lung ultrasound (LUS) is a promising point-of-care imaging technology for diagnosing pneumonia. The
objective was to explore LUS patterns associated with paediatric pneumonia.
Methods: We conducted a prospective, observational study among children aged 2 to 23 months with
World Health Organization Integrated Management of Childhood Illness chest-indrawing pneumonia and
among children without fast breathing, chest indrawing or fever (no pneumonia cohort) at two district
hospitals in Mozambique and Pakistan. We assessed LUS and chest radiograph (CXR) examinations, and
viral and bacterial nasopharyngeal carriage, and performed a secondary analysis of LUS patterns.
Results: LUS demonstrated a range of distinctive patterns that differed between children with and without
pneumonia and between children in Mozambique versus Pakistan. The presence of LUS consolidation or
interstitial patterns was more common in children with chest-indrawing pneumonia than in those without
pneumonia. Consolidations were also more common among those with only bacterial but no viral carriage
detected (50.0%) than among those with both (13.0%) and those with only virus detected (8.3%; p=0.03).
LUS showed high interrater reliability among expert LUS interpreters for overall determination of
pneumonia (κ=0.915), consolidation (κ=0.915) and interstitial patterns (κ=0.901), but interrater reliability
between LUS and CXR for detecting consolidations was poor (κ=0.159, Pakistan) to fair (κ=0.453,
Mozambique).
Discussion: Pattern recognition was discordant between LUS and CXR imaging modalities. Further
research is needed to define and standardise LUS patterns associated with paediatric pneumonia and to
evaluate the potential value of LUS as a reference standard.
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Introduction
Pneumonia remains the leading infectious killer of children [1]; effective and timely diagnosis is critical to
saving lives. Paediatric pneumonia is difficult to diagnose, especially in resource-constrained settings [2].
Advantages of ultrasound (LUS), a point-of-care tool that can dynamically visualise lungs with promising
diagnostic accuracy for pneumonia and greater sensitivity or specificity when compared with chest
radiography (CXR), include lower cost, portability, ease-of-use and absence of ionising radiation [3–5].
Key to evaluating the use case of LUS in pneumonia diagnosis in resource-constrained settings is a better
understanding of the LUS patterns associated with paediatric pneumonia. We conducted a pilot study in
Mozambique and Pakistan to investigate use of LUS for diagnosis and found that among children with
World Health Organization (WHO) Integrated Management of Childhood Illness (IMCI) chest-indrawing
pneumonia, expert LUS interpreters may achieve substantially higher interrater reliability (IRR) for LUS
compared to CXR [6]. We chose to focus on non-severe chest-indrawing pneumonia rather than more
severe pneumonia in this study, since we believed it unlikely that LUS imaging would change initial
management of severe pneumonia, which is typically treated with intravenous antibiotics. In this
secondary analysis, we explore distinctive LUS patterns associated with paediatric pneumonia and potential
patterns associated with viral and/or bacterial nasopharyngeal carriage.

Methods
Study design, setting and participants
Methods and primary results of this prospective, observational, facility-based cohort study were described
previously [6, 7]. The primary objective was to provide evidence assessing whether the addition of LUS to
current pneumonia care pathways improves identification of pneumonia in children presenting to district
hospitals in Manhiça, Mozambique and Karachi, Pakistan. Secondary and exploratory objectives included
identifying LUS patterns among children with and without chest-indrawing pneumonia and comparing
those patterns to CXR patterns. We explored LUS patterns, and available biomarker and viral and bacterial
nasopharyngeal carriage results.
Children aged 2 to 23 months meeting WHO IMCI chest-indrawing pneumonia case definition
(chest-indrawing pneumonia cohort) in outpatient and/or emergency departments of the low-volume,
rural Manhiça District Hospital in Manhiça, Mozambique and the high-volume, urban Sindh Government
Children’s Hospital–Poverty Eradication Initiative in Karachi, Pakistan were screened sequentially during
working hours by study staff to determine eligibility (table 1, figure 1). A separate group of 40 children
presenting with complaints of cough or difficulty breathing but without fast breathing, chest indrawing or
fever (no pneumonia cohort) was also screened. Conducted in accordance with the International
Conference on Harmonisation, Good Clinical Practice and Declaration of Helsinki 2008, the study was
approved by the Western Institutional Review Board, Comité Nacional de Bioética para a Saúde (246/
CNBS/17), Comite de Ética del Hospital Clínic de Barcelona (HCB/2017/0074) and Aga Khan University
Ethics Review Committee, and registered with ClinicalTrials.gov (NCT03187067).
Study procedures
After enrolment on Day 1, eligible children underwent history, physical examination and LUS and CXR
examinations. Enrolled children received local standard of care without the results of LUS examinations
informing clinical care.
LUS examinations (longitudinal and oblique scans obtained of the anterior, lateral and posterior sides of
the chest, figure 2) with a linear probe were performed by four trained non-physician healthcare personnel
(nurse and medical agent in Mozambique, and two radiology technicians in Pakistan) who received a
1-day standardised training course and 3-day supervised practice. LUS interpretation using a standardised
scoresheet targeted detection of typical lung consolidations, pleural effusions, interstitial patterns and
obstructive atelectasis [7, 8]. End-point pneumonia using LUS was defined as the presence of
consolidations or pleural effusions. At least two independent physicians expertly trained in LUS
interpretation and blinded to clinical presentation interpreted each examination. If discordant, a
designated expert LUS interpreter acted as arbiter. LUS operators at each site also interpreted LUS scans
independently from one another. All interpretations were performed in batches at a later time using the
same standardised scoresheet.
Anteroposterior CXR images were collected based on standard practice at each study
interpretation panel of six expert interpreters investigated radiographic indicators of
standardised primary end-point pneumonia [9–12]. At least three independent WHO
physicians interpreted each CXR. Three interpretations were randomly selected, and if
interpretations were discordant, the third would act as tiebreaker.
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TABLE 1 Study definitions and eligibility criteria
Definitions
Fast breathing for age
Severe respiratory distress
WHO IMCI general danger signs
Eligibility criteria
Inclusion criteria

Exclusion criteria

Children 2 to <12 months of age: RR ⩾50 breaths per min
Children ⩾12 months of age: RR ⩾40 breaths per min
Grunting, nasal flaring and/or head nodding
Lethargy or unconsciousness, convulsions, vomiting everything, inability to drink or breastfeed
Chest-indrawing pneumonia cohort
2 to 23 months of age
Cough <14 days or difficulty breathing
Visible indrawing of the chest wall with or without fast breathing for age
Ability and willingness of child’s caregiver to provide informed consent and to be available for
follow-up for the planned duration of the study, including accepting a home visit if he/she fails
to return for a scheduled study follow-up visit
No pneumonia cohort
2 to 23 months of age
Cough <14 days or difficulty breathing
Ability and willingness of child’s caregiver to provide informed consent and to be available for
follow-up for the planned duration of the study, including accepting a home visit if he/she fails
to return for a scheduled study follow-up visit
Chest-indrawing pneumonia cohort
Resolution of chest indrawing after bronchodilator challenge if wheezing at screening examination
Severe respiratory distress
Arterial SpO2 <90% in room air, as assessed noninvasively by a pulse oximeter
WHO IMCI general danger signs
Stridor when calm
Known or possible tuberculosis (history of a cough ⩾14 days)
Any medical or psychosocial condition or circumstance that, in the opinion of the investigators,
would interfere with the conduct of the study or for which study participation might jeopardise
the child’s health
Living outside the study catchment area
No pneumonia cohort
Axillary temperature ⩾38°C
Fast breathing for age
Visible indrawing of the chest wall
SpO2 <95% in room air, as assessed noninvasively by a pulse oximeter
WHO IMCI general danger signs
Stridor when calm
Known or possible tuberculosis (history of a cough ⩾14 days)
Any medical or psychosocial condition or circumstance that, in the opinion of the investigators,
would interfere with the conduct of the study or for which study participation might jeopardise
the child’s health
Living outside the study catchment area

RR: respiratory rate; WHO: World Health Organization; IMCI: Integrated Management of Childhood Illnesses; SpO2: oxyhaemoglobin saturation.

Blood samples were tested for haemoglobin and C-reactive protein in Mozambique and Pakistan, and for
procalcitonin, malaria and HIV in Mozambique. Nasopharyngeal aspirates and/or swabs were tested for
respiratory viral PCR in Mozambique and Pakistan, and bacterial PCR in Mozambique using commercial
multiplex tests.
Statistical analysis
Chi-squared tests, Fisher’s exact tests, and t-tests were used to compare baseline characteristics of children
by country and cohort. Tests were two-sided with α=0.05. Multiple comparison adjustments were not
made, given the exploratory aims of the analyses. IRR among expert LUS interpreters and among expert
CXR interpreters were estimated by cohort using Cohen’s kappa (κ). All analyses were performed using R
(version 3.5.1; R Foundation for Statistical Computing).

Results
Enrolment began in August 2017 in Mozambique and October 2017 in Pakistan. The last visits were
completed in June 2018 in Mozambique and April 2018 in Pakistan. Baseline LUS videos were available for
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a)

b)

Screened
(n=1867: 256 M, 1611 P)

Screened
(n=246: 22 M, 224 P)
Excluded (n=206: 2 M, 204 P)
Did not meet inclusion criteria
(n=153: 0 M, 153 P)
Declined to participate (n=49: 2 M, 47 P)
Other reasons (n=4: 0 M, 4 P)

Excluded (n=1637: 156 M, 1481 P)
Did not meet inclusion criteria# (n=1475: 122 M, 1353 P)
Declined to participate (n=99: 24 M, 75 P)
Other reasons (n=63: 10 M, 53 P)
Enrolled
(n=230: 100 M, 130 P)
Excluded from analysis due to missing lung ultrasound
(n=4: 2 M, 2 P)
Missing chest radiograph and lung ultrasound
(n=1: 0 M, 1 P)
Missing lung ultrasound only (n=3: 2 M, 1 P)
Analysed
(n=226: 98 M, 128 P)

Enrolled and analysed
(n=40: 20 M, 20 P)

FIGURE 1 a) Flow of children with chest-indrawing pneumonia by country: Mozambique (M) and Pakistan (P). b) Flow of children with no fast
breathing, no chest indrawing and no fever by country. #: 70 children in Mozambique (27.3% of screened) and 1318 children in Pakistan (81.8% of
screened) met the “no chest indrawing” exclusion criterion.

98 out of 100 and 128 out of 130 children with chest-indrawing pneumonia in Mozambique and Pakistan,
respectively (figure 1a), and all 40 in the no pneumonia cohort (figure 1b), with baseline characteristics by
cohort and country provided in table 2. One child with an oxyhaemoglobin saturation <90% was
incorrectly enrolled in the chest-indrawing pneumonia cohort in Mozambique. The results reflect the
available data from these 226 children in the chest-indrawing pneumonia cohort and 40 children in the no
pneumonia cohort. Among children with pneumonia, there were more fevers (21.4% versus 8.6%, p=0.01),
but less fast breathing (53.1% versus 64.6%, p=0.10) in Mozambique than Pakistan. One child had
hypoxaemia in Mozambique and none in Pakistan. C-reactive protein measurements were available for 93
and 128 children with pneumonia in Mozambique and Pakistan, respectively, and were on average lower in
Mozambique than Pakistan (38.8 versus 109.9 µg·mL−1, p<0.01). Among children without pneumonia,
C-reactive protein measurements were available in Mozambique, and on average were lower than those
among children with pneumonia (18.2 versus 38.8 µg·mL−1, p=0.03). Procalcitonin measurements were
available for 93 children with pneumonia and 20 children without pneumonia in Mozambique. Average
levels were higher in the former group (1.7 ng·mL−1) than the latter (0.2 ng·mL−1) (p=0.07).
Nasopharyngeal viral carriage results were available for 98 children with pneumonia and 20 children
without pneumonia analysed from Mozambique, and 100 children with pneumonia analysed from
Pakistan (supplementary appendix 1). Presence of any respiratory virus was similarly high across all tested
children in both countries (91.8% Mozambique pneumonia; 84% Pakistan pneumonia; 95% Mozambique
no pneumonia). However, the average number of viruses per child was higher among children with
pneumonia in Mozambique (1.67) than in Pakistan (1.08; p<0.01) or among children without pneumonia
in Mozambique (1.25; p=0.01).

a)

b)

Parasternal line
Anterior

Scapula
Posterior

Anterior axillary line
Spine line

Lateral
Posterior axillary line
Posterior

FIGURE 2 Lung ultrasound examinations consisted of longitudinal and oblique scans obtained of the anterior, lateral and posterior sides of the
child’s chest.
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TABLE 2 Baseline characteristics of enrolled and analysed children by cohort and country
Chest-indrawing pneumonia cohort
Pakistan

98
10.9±6.0
55 (56.1%)
39 (39.8%)
37.1±1.1
21 (21.4%)

128
6.8±4.8
111 (86.7%)
34 (26.6%)
36.7±0.8
11 (8.6%)

<0.01
<0.01
0.049
<0.01
0.01

52.5±11.4
44.3±10.0
52 (53.1%)
97.8±2.6
1 (1.0%)
10.0±1.3
0 (0.0%)
1 (1.0%)
38.8±49.8
1.7±7.2
84 (86.6%)
3 (3.1%)
0 (0.0%)
0 (0.0%)
3 (3.1%)

53.5±7.9
47.6±9.6
83 (64.8%)
95.3±2.2
0 (0.0%)
10.7±1.3

0.58
0.23
0.10
<0.01
0.43
<0.01

109.9±199.7

<0.01

1.67±1.04
90 (91.8%)
41 (41.8%)
30 (30.6%)
19 (19.4%)

1.08±0.65
84 (84.0%)
61 (61.0%)
22 (22.0%)
1 (1.0%)

Between-country
comparison p-value

<0.01
0.14

Mozambique

Pakistan

20
11.0±6.1
12 (60.0%)
14 (70.0%)
36.3±0.6
0 (0.0%)

20
7.6±4.8
15 (75.0%)
12 (60.0%)
36.3±0.6
0 (0.0%)

39.7±7.1
34.4±4.2
0 (0.0%)
96.2±1.5
0 (0.0%)
10.3±1.0
0 (0.0%)
0 (0.0%)
18.2±33.9
0.2±0.6

38.8±4.8
32.2±4.5
0 (0.0%)
96.8±1.6
0 (0.0%)
9.4±1.5

Between-cohort
comparison p-value

Between-country
comparison p-value

Mozambique

Pakistan

0.06
0.50
0.74
0.72

0.91
0.94
0.03
<0.01
0.02

0.45
0.18
<0.01
0.02
0.36

0.72
0.41

<0.01
<0.01
<0.01
<0.01
>0.99
0.37
>0.99
>0.99
0.03
0.07

<0.01
<0.01
<0.01
<0.01

0.23
0.04

0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)

>0.99

1.25±0.55
19 (95.0%)
13 (65.0%)
6 (30.0%)
0 (0.0%)

0.01
0.31

<0.01

>0.99

Data are presented as mean±SD or n (%), unless otherwise stated. #: HIV testing only conducted in Mozambique; missing for 55 children with chest-indrawing pneumonia. ¶: malaria
testing only conducted in Mozambique; missing for two children with chest-indrawing pneumonia. +: C-reactive protein missing for five children with chest-indrawing pneumonia in
Mozambique; in Pakistan, only measured for children with chest-indrawing pneumonia. §: procalcitonin only measured in Mozambique; missing for five children with chest-indrawing
pneumonia. ƒ: S. pneumoniae carriage only tested for 97 children with chest-indrawing pneumonia in Mozambique. ##: B. pertussis, C. pneumophila, L. pneumophila and M. pneumoniae
carriage only tested in Mozambique; all children with B. pertussis were also positive for S. pneumoniae, and two of the three children with M. pneumoniae were also positive for
S. pneumoniae; no children were positive for both B. pertussis and M. pneumoniae. ¶¶: viral carriage in Pakistan only tested in 100 analysed children with chest-indrawing pneumonia.
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Subjects n
Age months
<12 months
Female
Temperature °C
Fever (⩾38°C) n (%)
Respiratory rate breaths per min
<12 months
⩾12 months
Fast breathing
Oxyhaemoglobin saturation %
<90% n (%)
Haemoglobin g·dL−1
Positive HIV rapid diagnostic test#
Positive malaria rapid diagnostic test¶
C-reactive protein+ µg·mL−1
Procalcitonin§ ng·mL−1
Streptococcus pneumoniaeƒ
Bordetella pertussis##
Chlamydophila pneumophila##
Legionella pneumophila##
Mycoplasma pneumoniae##
Nasopharyngeal viral PCR¶¶
Number of viruses detected
Any viruses detected
1 virus detected
2 viruses detected
⩾3 viruses detected

Mozambique

No pneumonia cohort

LUNG IMAGING | A.S. GINSBURG ET AL.

Streptococcus pneumoniae nasopharyngeal carriage results were available for 97 children with pneumonia
in Mozambique, while remaining bacterial carriage results were available for all 100 children with
pneumonia and 20 children without pneumonia in Mozambique. Most children with pneumonia in
Mozambique tested positive for S. pneumoniae (86.6%); 3.1% were positive for Bordetella pertussis and
3.1% for Mycoplasma pneumoniae (table 2). No children without pneumonia were positive for carriage of
any of the tested bacterial strains.
Among 97 children with pneumonia in Mozambique for whom both viral and bacterial carriage results
were available, eight were positive for at least one bacterial but no viral carriage, 12 were positive for at
least one viral but no bacterial carriage and 77 were positive for at least one of both; no children were
negative for all tested strains of both (table 3). Among viral-only positives, respiratory syncytial virus
(RSV) and rhinovirus were the only strains that appeared without additional viruses in more than one
child (three and two, respectively). Among mixed (both viral and bacterial) positives, RSV with S.
pneumoniae (14 children), rhinovirus with S. pneumoniae (eight children) and adenovirus with rhinovirus
with S. pneumoniae (seven children) were the three most common combinations present. Other
combinations were each present in four or fewer children.

LUS patterns
Presence of any LUS consolidation was more common in children with chest-indrawing pneumonia than
those without pneumonia (15.3% versus 0.0%, p=0.07, Mozambique; 45.5% versus 5.0%, p<0.01, Pakistan)
as was presence of any LUS interstitial pattern (24.5% versus 10.0%, p=0.24, Mozambique; 62.5% versus
30.0%, p=0.01, Pakistan, table 4). Neither LUS presence of pleural effusion nor obstructive atelectasis was
significantly different between those with and without pneumonia in Mozambique (0.0% throughout) or
Pakistan (1.6% versus 0.0%, p>0.99; 2.3% versus 0.0%, p>0.99, respectively). Among those with pneumonia,
LUS consolidation and interstitial patterns were significantly more common in Pakistan than Mozambique
( p<0.01 for each comparison), though LUS effusion and obstructive atelectasis were not ( p=0.51; p=0.26,
respectively). Among those without pneumonia, consolidation and interstitial patterns were not
significantly more common in Pakistan than Mozambique ( p>0.99; p=0.24, respectively), and effusion and
obstructive atelectasis patterns were absent in all children.
Expert LUS interpreters showed very high levels of IRR in overall determination of pneumonia (κ=0.915),
consolidation (κ=0.915), effusion (κ=1) and interstitial patterns (κ=0.901) among children with pneumonia;
estimated IRR was lower, but still moderate to good for obstructive atelectasis (κ=0.746) (table 5). Of note,
the unusual κ=1 occurred because of very small numbers of children with pleural effusions.
When both expert LUS interpreters determined a given imaging pattern was absent for all children, the
κ-value for that imaging pattern was undefined, as was true for children without pneumonia with respect
to presence of effusion and obstructive atelectasis. Among children without pneumonia, IRRs for overall
pneumonia and for consolidations were estimated to be 1, but these were due to the small number of

TABLE 3 Baseline lung ultrasound pattern by nasopharyngeal carriage in the chest-indrawing pneumonia cohort in
Mozambique
Chest-indrawing pneumonia cohort in Mozambique

Subjects n
Any consolidation
Peripheral
Lobar
Present in both lungs
Any pleural effusion
Any interstitial pattern
Focal
Multifocal
Present in both lungs
Any obstructive atelectasis

Bacteria but
no viruses detected

Viruses but
no bacteria detected

Both bacteria and
viruses detected

8
4 (50.0%)
2 (25.0%)
2 (25.0%)
1 (12.5%)
0 (0.0%)
4 (50.0%)
4 (50.0%)
1 (12.5%)
1 (12.5%)
0 (0.0%)

12
1 (8.3%)
1 (8.3%)
1 (8.3%)
1 (8.3%)
0 (0.0%)
4 (33.3%)
4 (33.3%)
0 (0.0%)
2 (16.7%)
0 (0.0%)

77
10 (13.0%)
8 (10.4%)
2 (2.6%)
2 (2.6%)
0 (0.0%)
16 (20.8%)
16 (20.8%)
0 (0.0%)
5 (6.5%)
0 (0.0%)

Carriage type
comparison p-value

0.03

0.14

Data are presented as n (%) unless otherwise stated. Both bacterial and viral carriage assessed in Mozambique. Pakistan did not have
bacterial carriage testing conducted.
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TABLE 4 Baseline lung ultrasound imaging patterns of children by cohort and country
Chest-indrawing pneumonia cohort

Subjects n
Any consolidation
Peripheral
Lobar
Present in both
lungs
Any pleural
effusion
Simple
Complex
Present in both
lungs
Any interstitial
pattern
Focal
Multifocal
Present in both
lungs
Any obstructive
atelectasis
Present in both
lungs

Mozambique

Pakistan

98
15 (15.3%)
11 (11.2%)
5 (5.1%)
4 (4.1%)

128
57 (44.5%)
51 (39.8%)
18 (14.1%)
18 (14.1%)

0 (0.0%)

2 (1.6%)

0 (0.0%)
0 (0.0%)
0 (0.0%)

2 (1.6%)
0 (0.0%)
0 (0.0%)

24 (24.5%)

80 (62.5%)

24 (24.5%)
1 (1.0%)
8 (8.2%)

64 (50.0%)
28 (21.9%)
46 (35.9%)

0 (0.0%)

3 (2.3%)

0 (0.0%)

0 (0.0%)

Between-country
comparison
p-value

No pneumonia cohort
Mozambique

Pakistan

<0.01

0
0
0
0

20
(0.0%)
(0.0%)
(0.0%)
(0.0%)

20
1 (5.0%)
1 (5.0%)
0 (0.0%)
0 (0.0%)

0.51

0 (0.0%)

0 (0.0%)

0 (0.0%)
0 (0.0%)
0 (0.0%)

0 (0.0%)
0 (0.0%)
0 (0.0%)

2 (10.0%)

6 (30.0%)

2 (10.0%)
0 (0.0%)
0 (0.0%)

6 (30.0%)
1 (5.0%)
4 (20.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

<0.01

0.26

Between-cohort
comparison p-value

Between-country
comparison
p-value

Mozambique

Pakistan

>0.99

0.07

<0.01

>0.99

0.24

0.24

0.01

>0.99

Data are presented as n (%) unless otherwise stated.

children with any findings on LUS. IRR for interstitial patterns was moderate (κ=0.635), but again,
numbers were small.
No additional patterns of differences in LUS results were evident when comparing children with and
without viral nasopharyngeal carriage (data not presented). Among children with pneumonia in
Mozambique for whom viral and bacterial nasopharyngeal carriage results were available, presence of
consolidations differed significantly between bacterial-only, mixed positives and viral-only (50.0% versus
13.0% versus 8.3%, p=0.03); other imaging patterns did not (table 3).
CXR patterns
Differences in presence of CXR imaging patterns between cohorts within each country were not significant
except for interstitial patterns in Pakistan. CXR interstitial patterns were common in both countries for
children with pneumonia (36.1%) and less common among those without pneumonia in Mozambique

TABLE 5 Inter rater reliability among lung ultrasound experts

Overall pneumonia
Consolidation
Pleural effusion
Interstitial pattern
Obstructive atelectasis

Chest-indrawing
pneumonia cohort # κ

No pneumonia cohort ¶ κ

0.915
0.915
1+
0.901
0.746

1+
1+
0.635

Testing of κ only signifies that the level of inter rater reliability differs from what would occur by chance
(κ=0). Thus, p-values are not noted for κ results. #: n=226. ¶: n=40. +: based on small counts for one of the
two possible categories of inter rater reliability, with two or fewer children in the smaller category.
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(15.0%, p=0.12) and Pakistan (10.0%, p=0.04). Presence of CXR consolidation was more common in
Mozambique than Pakistan in both chest-indrawing pneumonia and no pneumonia cohorts (18.6% versus
9.8%, p=0.09; 20.0% versus 0.0%, p=0.11, respectively) (supplementary appendix 2). Presence of effusion
was detected by CXR in one child with pneumonia in Mozambique (1.0%), while obstructive atelectasis
was detected by CXR in one child with pneumonia in Pakistan (0.8%).
Comparison of LUS and CXR patterns
In assessing concordance between expert LUS versus expert CXR interpretations regarding presence of
consolidation in the chest-indrawing pneumonia cohort, κ=0.453 for Mozambique and κ=0.159 for
Pakistan; for the no pneumonia cohort, four consolidations were detected by LUS but none by CXR in
Mozambique, resulting in κ=0, and one was detected by CXR but none by LUS in Pakistan, also resulting
in κ=0 (supplementary appendix 3). Regarding presence of effusion in the pneumonia cohort (data not
shown), although two were detected by LUS in Pakistan, none were detected by CXR, resulting in κ=0;
likewise, 1 was detected by CXR in Mozambique but none by LUS, also resulting in κ=0. Corresponding
κ-values were undefined for those without pneumonia because no effusions were detected by either
modality.

Discussion
In our pilot, LUS demonstrated a range of distinctive patterns that differed between children in the
chest-indrawing pneumonia and no pneumonia cohorts and between children in Mozambique versus
Pakistan. Presence of consolidation or interstitial patterns was more common in children diagnosed with
chest-indrawing pneumonia based on WHO IMCI criteria than in those without pneumonia. Presence of
pleural effusion or obstructive atelectasis patterns was not significantly different among those children with
and without pneumonia, though this was based on small numbers of LUS effusions and obstructive
atelectasis. In Pakistan, differences in identification of consolidation and interstitial patterns between those
with and without pneumonia were statistically significant. Rates of consolidation and interstitial patterns
were significantly higher in Pakistan than Mozambique, possibly due to differences in severity of disease
for those eligible and enrolled. Other possible explanations for the different LUS patterns observed among
children with chest-indrawing pneumonia include differing epidemiologies of etiological pathogens,
presentations of disease, host susceptibility and environmental factors, healthcare-seeking behaviours, and
healthcare facility levels (low-volume, rural district hospital in Mozambique and high-volume urban
hospital in Pakistan), among others.
Among children with chest-indrawing pneumonia, most children with consolidation also had interstitial
patterns in one or both lungs (12 out of 15 (80.0%), Mozambique and 54 out of 57 (94.7%), Pakistan). Of
those children with chest-indrawing pneumonia with interstitial patterns, 50% (12 out of 24) in
Mozambique and 32.5% (26 out of 80) in Pakistan demonstrated interstitial patterns without
consolidation. Thus, children with chest-indrawing pneumonia demonstrate a mix of LUS patterns.
Among children with chest-indrawing pneumonia in Mozambique, consolidations were detected at a
higher rate in those with bacterial carriage only (no viral carriage), and more frequently but to a lesser
extent among those with mixed bacterial and viral carriage, than among those with viral carriage only.
Interstitial patterns were again most frequent among those with bacterial carriage, but least frequent
among those with mixed bacterial and viral carriage. One could hypothesise that LUS might be able to
assist with etiological detection although in the absence of microbiological diagnosis and confirmation,
more research would be necessary. It is not surprising that we find a high percentage of nasopharyngeal
carriage in children without pneumonia, but this also implies that these comparisons between carriage and
disease are not necessarily indicative of clinical disease status or severity. In a study evaluating LUS use
during the 2009 H1N1 influenza A pandemic, investigators defined viral pneumonia as the presence of
small subpleural consolidations usually <0.5 cm and/or individual B-lines or confluent B-lines (interstitial
pattern), and bacterial pneumonia as the presence of lung consolidation with air bronchograms, and based
on 54 observations found that IRR for distinguishing viral from bacterial pneumonia was 0.82 (0.63 to
0.99) [13].
While some variability in LUS pattern findings exists, in our study, LUS appears to be consistent with
clinical presentation in identifying consolidation (except for one child in the no pneumonia cohort in
Pakistan identified with consolidation on LUS). In the no pneumonia cohort LUS appears to overdiagnose
interstitial patterns (eight children) while CXR appears to overdiagnose both consolidation (four children)
and interstitial patterns (five children). Abnormal imaging patterns in the absence of clinical disease could
lead to overtreatment with antibiotics.
Based on our limited sample, IRR between LUS and CXR was poor in identifying consolidation and
pneumonia. Using LUS, it appears there is significantly more disease in Pakistan than Mozambique;
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however, using CXR, the opposite seems true (although not significantly). Depending on which imaging
modality is used, there is different recognition of disease. The fact that recognition of disease on imaging
differs between the study sites by imaging modality may appear paradoxical; however, this may be due to
chance or to a lack of an imaging gold standard, making it unclear whether it is LUS or CXR that is
performing poorly.
Because study populations and underlying epidemiologies were different between Mozambique and
Pakistan, and sample sizes of enrolled children were relatively small at each study site, there were
limitations in comparisons that could be made between sites, and between pneumonia and no pneumonia
cohorts. Of note, of those screened, 81.8% in Pakistan versus 27.3% in Mozambique were not enrolled
because they did not have chest indrawing. Possible explanations for this difference could include
differences in healthcare-seeking behaviour at the two study sites and/or differences in screening
procedures. Importantly, though, great care was undertaken to ensure that all eligibility criteria were met at
both study sites. Enrolment in the pneumonia cohort in Mozambique was slower due to smaller
presenting numbers than in Pakistan as evidenced by larger differences in those screened versus enrolled
in Pakistan, and this may have led to sicker children being enrolled in Pakistan (as suggested by higher
average C-reactive protein measurement, lower average oxyhaemoglobin saturations, and more LUS
consolidation and interstitial patterns in Pakistan).
Additional limitations related to imaging interpretation. For LUS interpretation, detailed expert consensus
on what constitutes clinically relevant disease does not exist. While LUS videos were reviewed
independently, our expert reviewers were not completely independent because one had been trained by the
other. For CXR interpretation methodology, despite being used widely for epidemiological and vaccine
effectiveness studies, current WHO CXR interpretation methodology is not intended for clinical use; rather
it is intended to serve as a research end-point, and thus, our expert CXR interpretations may miss more
subtle disease.
Apart from being difficult to obtain, time-consuming, expensive and exposing its subject to ionising
radiation, CXR is also not an ideal reference standard due to its high interrater variability [2–4, 12, 14–19].
In our study, CXR had poor IRR, even among expert CXR interpreters. Pattern recognition was discordant
between LUS and CXR imaging modalities. Despite this discordance, LUS imaging may be preferable in
identifying patterns; however, further research is needed to define and standardise LUS patterns associated
with paediatric pneumonia. In addition, while more data may be needed to support LUS as a reference
standard, in favour of LUS as a preferred imaging modality for paediatric pneumonia is its high IRR
among expert LUS interpreters for overall determination of pneumonia, consolidation and interstitial
patterns. LUS pattern recognition and image analysis is a potential tool to allow machine-learning and
artificial intelligence-assisted automatic diagnosis of pneumonia. More research is needed to define and
standardise LUS patterns associated with paediatric pneumonia and to evaluate the potential value of LUS
as a reference standard.
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